Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology

Laboratory Investigation

Volumn 77, Issue 1, 1997, Pages 103-108

  Carlson, Ilene ^a   Tognazzi, Kathi ^a   Manseau, Eleanor J ^a   Dvorak, Harold F ^a   Brown, Lawrence F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ARTICLE; CLINICAL ARTICLE; GIANT CELL; GRANULOMATOUS INFLAMMATION; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BIOPSY; CELL ADHESION; ERYTHEMA NODOSUM; GASTRITIS; GRANULOMA; HISTIOCYTES; HUMANS; IN SITU HYBRIDIZATION; OSTEOPONTIN; PHOSPHOPROTEINS; RABBITS; RNA, MESSENGER; ROSACEA; SARCOIDOSIS; SIALOGLYCOPROTEINS;

EID: 0030799667     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bellahcene A and Castronovo V (1995). Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:95-100.
2. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, and Mukherjee BB (1994). Osteopontin: Its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem 115:675-682.
3. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, and Senger DR (1992). Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169-1180.
4. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, and Senger DR (1994). Osteopontin expression and distribution in human carcinomas. Am J Pathol 145:610-623.
5. Chambers AF, Behrend EI, Wilson SM, and Denhardt DT (1992). Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res 12:43-47.
6. Chambers AF, Hota C, and Prince CW (1993). Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res 53:701-706.
7. Chen J, Singh K, Mukherjee BB, and Sodek J (1993). Developmental expression of osteopontin (OPN) mRNA in rat tissues: Evidence for a role for OPN in bone marrow formation and resorption. Matrix 13:113-123.
8. Cotran RS, Robbins SL, and Kumar V, editors (1994). Robbins pathologic basis of disease. Philadelphia: W. B. Saunders, 81-82.
9. Craig AM, Nemir M, Mukherjee BB, Chambers AF, and Denhardt DT (1988). Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: Enhanced expression in H-ras-transformed 3T3 cells. Biochem Biophys Res Commun 157:166-173.
10. Denhardt DT and Chambers AF (1994). Overcoming obstacles to metastasis-defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56:48-51.
11. Fitzpatrick LA, Severson A, Edwards WD, and Ingram RT (1994). Diffuse calcification in human coronary arteries, association of osteopontin with atherosclerosis. J Clin Invest 94:1597-1604.
12. Flory CM, Jones ML, Miller BF, and Warren JS (1995). Regulatory roles of tumor necrosis factor-α and interleukin-1b in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Pathol 146:450-462.
13. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, and Schwartz SM (1993). Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696.
14. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, and Nomura S (1993). Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification. Am J Pathol 143:1003-1008.
15. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, and Hirokawa K (1993). Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92:2814-2820.
16. Jee WSS and Nolan PD (1963). Origin of osteoclasts from the fusion of phagocytes. Nature 200:225-226.
17. Klingemann HG and Dedhar S (1989). Distribution of integrins on human peripheral blood mononuclear cells. Blood 74: 1348-1354.
18. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki T, Sinohara H, and Kurita T (1993). Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184.
19. Krissansen GW, Elliott MJ, Lucas CM, Stomski FC, Berndt MC, Cheresh DA, Lopez AF, and Burns GF (1990). Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. J Biol Chem 265:823-830.
20. 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 77:665-672.
21. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, and Schwartz SM (1995b). The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 95:713-724.
22. Mark MP, Prince CW, Gay S, Austin RL, and Butler WT (1988). 44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: Kidney and nervous tissues. Cell Tissue Res 251:23-30.
23. McKee MD and Nanci A (1996). Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis. Anat Rec 245: 394-409.
24. Merry K, Dodds R, Littlewood A, and Gowen M (1993). Expression of osteopontin mRNA by osteoclasts and osteoblasts in modeling adult human bone. J Cell Sci 104:1013-1020.
25. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 266:20369-20374.
26. Miyazaki Y, Tashiro T, Higuchi Y, Setoguchi M, Yamamoto S, Nagai H, Nasu M, and Vassalli P (1995). Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of tumor necrosis factor-alpha transgene. Ann N Y Acad Sci 760:334-341.
27. Moore MA, Gotoh Y, Rafidi K, and Gerstenfeld LC (1991). Characterization of cDNA for chicken osteopontin: Expression during bone development, osteoblast differentiation, and tissue distribution. Biochemistry 30:2501-2508.
28. Murry CE, Giachelli CM, Schwartz SM, and Vracko R (1994). Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450-1462.
29. Nomura S, Wills AJ, Edwards DR, Heath JK, and Hogan BL (1988). Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106:441-450.
30. Oldberg A, Franzen A, and Heinegard D (1986). Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823.
31. Patarca R, Saavedra RA, and Cantor H (1993). Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early t-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13:225-246.
32. Prince CW, Dickie D, and Krumdieck CL (1991). Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun 177:1205-1210.
33. Reinholt FP, Hultenby K, Oldberg A, and Heinegard D (1990). Osteopontin-a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475.
34. 3 potentiate bone resorption. J Biol Chem 268:9901-9907.
35. Senger DR, Asch BB, Smith BD, Perruzzi CA, and Dvorak HF (1983). A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 302:714-715.
36. 3 integrin, osteopontin, and thrombin. Am J Pathol 149:293-305.
37. Senger DR, Perruzzi CA, Papadopoulos A, and Tenen DG (1989). Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 996:43-48.
38. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, and Van De Water L (1994). Adhesive properties of osteopontin: Regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5:565-574.
39. Senger DR, Wirth DF, and Hynes RO (1980). Transformation-specific secreted phosphoproteins. Nature 286:619-621.
40. Setoguchi K, Takeya M, Akaike T, Suga M, Hattori R, Maeda H, Ando M, and Takahashi K (1996). Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am J Pathol, 149:2005-2022.
41. Singh RP, Patarca R, Schwartz J, Singh P, and Cantor H (1990). Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942.
42. v integrin subunit and osteopontin during differentiation of HL-60 cells along the monocytic pathway. Exp Cell Res 216:335-341.
43. Somerman MJ, Prince CW, William TB, Foster RA, Moehring JM, and Sauk JJ (1989). Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix 9:49-54.
44. Sorensen ES, Rasmussen LK, Moller L, Jensen PH, Hojrup P, and Peterson TE (1994). Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem J 304:13-16.
45. Yoon K, Buenaga R, and Rodan GA (1987). Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun 148:1129-1136.